Must Read Rumors

Beauty therapist presented as Kate Middleton’s beautician has never worked for her

Duchess Kate is admired not only for her style, but also for her beauty.

Duchess Kate stuns at Bafta awards in Alexander McQueen gown

The 2017 British Academy Film Awards ceremony brought together the world’s top actors and filmmakers in London.

Kate Middleton pregnant: bets placed on royal baby in 2017

Lately speculation has surfaced surrounding a third royal pregnancy. Should we expect royal baby no. 3 this year?

Kate Middleton themed café opens in Australia

The Duchess of Cambridge, née Kate Middleton, has become an inspiration in ways that not even the royal herself would imagine.

Beauty therapist presented as Kate Middleton’s beautician has never worked for her
Duchess Kate stuns at Bafta awards in Alexander McQueen gown
Kate Middleton pregnant: bets placed on royal baby in 2017
Kate Middleton pregnancy and surrogacy rumors denied
Kate Middleton themed café opens in Australia

The Bluetooth pill to appear in European hospitals soon

by Nicole
November 12, 2010 at 3:22 pm

Miniaturization has always been a safe way to remarkable advances in microprocessor industry, allowing not only the manufacturing of microchips, but also a greater degree of integration for equipment with a high degree of complexity.

One of the areas that most benefit this is medicine, a domain in which miniaturization has enabled the creation of more sophisticated prostheses, and intelligent diagnostic equipment, small enough to fit inside a capsule.

One of the first companies to bring such devices in mass production is Novartis AG Sweden, with its “Ingestible Event Marker.” Small enough to be incorporated into the pill capsules, this microchip, activated after ingestion by contact with the stomach acids, may send biometric information to assess the effectiveness of the administered drug.

Parameters such as body temperature, heart rate and movements of the patient can be monitored, as information is transmitted in real time via Bluetooth.

Initially, this technology will be used only for monitoring high-risk patients such as those undergoing transplant operations, but could be extended to other areas.

If tests show that adding such microchips does not change the curative properties of pills, the product could be approved for general use in European countries over the next 18 months.

What do you think? What is your gossip?

The rules: Keep it clean, stay on the subject and use English only - or we may delete your comment. If you see inappropriate language email us. Read our Terms and Conditions